rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-9-4
|
pubmed:abstractText |
Fabry disease is an X-linked multisystem disorder. Enzyme-replacement therapy in adults has limited efficacy in treating major sequelae of advanced Fabry disease, such as kidney failure or stroke. This prompted a study of the safety and efficacy of enzyme replacement at an earlier stage of Fabry disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1098-4275
|
pubmed:author |
pubmed-author:BeckMichaelM,
pubmed-author:BradyRoscoe ORO,
pubmed-author:ClarkeJoe T RJT,
pubmed-author:KampmannChristophC,
pubmed-author:LienY HowardYH,
pubmed-author:PastoresGregoryG,
pubmed-author:RiesMarkusM,
pubmed-author:RobinsonChevaliaC,
pubmed-author:SchiffmannRaphaelR,
pubmed-author:SchlaggarBradley LBL,
pubmed-author:TimmonsMargaretM,
pubmed-author:WhybraCatharinaC
|
pubmed:issnType |
Electronic
|
pubmed:volume |
118
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
924-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16950982-Adolescent,
pubmed-meshheading:16950982-Antibody Formation,
pubmed-meshheading:16950982-Autonomic Nervous System,
pubmed-meshheading:16950982-Child,
pubmed-meshheading:16950982-Fabry Disease,
pubmed-meshheading:16950982-Female,
pubmed-meshheading:16950982-Heart Rate,
pubmed-meshheading:16950982-Humans,
pubmed-meshheading:16950982-Isoenzymes,
pubmed-meshheading:16950982-Male,
pubmed-meshheading:16950982-Treatment Outcome,
pubmed-meshheading:16950982-alpha-Galactosidase
|
pubmed:year |
2006
|
pubmed:articleTitle |
Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease.
|
pubmed:affiliation |
Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1260, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, N.I.H., Intramural
|